Investor Relations Captor Therapeutics ®
Information on expiration of pledge in Company shares under Article 19 MAR
Current report no. 45/2022
Date of drafting: 8 December 2022.
Subject: Information on expiration of pledge in Company shares under Article 19 MAR
Legal basis: Article 19 (3) MAR - information on transactions performed by persons discharging managerial responsibilities
The Management Board of Captor Therapeutics S.A. based in Wrocław ("the Company") informs that it received from Michał Walczak, Management Board Member, the notification regarding expiration of the registered pledge established on the Company's shares under Article 19(1) of the MAR Regulation (information on the establishment of the pledge in shares was provided in current report no. 32/2022 dated 9 August 2022).
The content of the notification is attached to this report.